rs797045525
Positions:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_021120.4(DLG3):c.1405+5_1405+7delGAG variant causes a splice region, intron change. The variant allele was found at a frequency of 0.000303 in 1,197,885 control chromosomes in the GnomAD database, including 2 homozygotes. There are 95 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0015 ( 2 hom., 45 hem., cov: 23)
Exomes 𝑓: 0.00018 ( 0 hom. 50 hem. )
Consequence
DLG3
NM_021120.4 splice_region, intron
NM_021120.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.18
Genes affected
DLG3 (HGNC:2902): (discs large MAGUK scaffold protein 3) This gene encodes a member of the membrane-associated guanylate kinase protein family. The encoded protein may play a role in clustering of NMDA receptors at excitatory synapses. It may also negatively regulate cell proliferation through interaction with the C-terminal region of the adenomatosis polyposis coli tumor suppressor protein. Mutations in this gene have been associated with X-linked cognitive disability. Alternatively spliced transcript variants have been described. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant X-70454318-TAGG-T is Benign according to our data. Variant chrX-70454318-TAGG-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 210850.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1, Benign=2}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00154 (172/111692) while in subpopulation AFR AF= 0.00539 (166/30781). AF 95% confidence interval is 0.00472. There are 2 homozygotes in gnomad4. There are 45 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLG3 | NM_021120.4 | c.1405+5_1405+7delGAG | splice_region_variant, intron_variant | ENST00000374360.8 | NP_066943.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLG3 | ENST00000374360.8 | c.1405+5_1405+7delGAG | splice_region_variant, intron_variant | 1 | NM_021120.4 | ENSP00000363480.3 |
Frequencies
GnomAD3 genomes AF: 0.00154 AC: 172AN: 111637Hom.: 2 Cov.: 23 AF XY: 0.00133 AC XY: 45AN XY: 33847
GnomAD3 genomes
AF:
AC:
172
AN:
111637
Hom.:
Cov.:
23
AF XY:
AC XY:
45
AN XY:
33847
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000504 AC: 91AN: 180568Hom.: 1 AF XY: 0.000292 AC XY: 19AN XY: 65144
GnomAD3 exomes
AF:
AC:
91
AN:
180568
Hom.:
AF XY:
AC XY:
19
AN XY:
65144
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000176 AC: 191AN: 1086193Hom.: 0 AF XY: 0.000142 AC XY: 50AN XY: 351899
GnomAD4 exome
AF:
AC:
191
AN:
1086193
Hom.:
AF XY:
AC XY:
50
AN XY:
351899
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00154 AC: 172AN: 111692Hom.: 2 Cov.: 23 AF XY: 0.00133 AC XY: 45AN XY: 33912
GnomAD4 genome
AF:
AC:
172
AN:
111692
Hom.:
Cov.:
23
AF XY:
AC XY:
45
AN XY:
33912
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 03, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 01, 2014 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
DLG3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 28, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 13
Find out detailed SpliceAI scores and Pangolin per-transcript scores at